:: Altroz - News Magazine HTML Template ::

Language:

diabetes News

Novo Nordisk and Septerna Forge Groundbreaking $2.2 Billion Partnership to Revolutionize Obesity and Diabetes Treatment

Michael Lee 14 May, 2025

Novo Nordisk and Septerna have entered a $2.2 billion partnership to develop oral treatments for obesity and type 2 diabetes, combining Danish research excellence with U.S. biotech...

Business

Eli Lilly Expands Horizons: Launching Revolutionary Weight Loss Drug in China and India

Christopher Adams 11 Mar, 2025

Eli Lilly & Co. plans to introduce Mounjaro, its diabetes and weight-loss medication, in China, India, Brazil, and Mexico, targeting up to 900 million patients. The move comes as d...

diabetes News

Novo Nordisk and Septerna Forge Groundbreaking $2.2 Billion Partnership to Revolutionize Obesity and Diabetes Treatment

Eli Lilly Expands Horizons: Launching Revolutionary Weight Loss Drug in China and India

Popular News

Amazon Announces Closure of Quebec Operations, Impacting Nearly 2,000 Jobs

Elon Musk Announces Starlink's Emergency Deployment to Safeguard Air Traffic Control

Record-Breaking Surge: Equity Mutual Fund Inflows Skyrocket to Nearly Rs 4 Lakh Crore in 2024

Rupee Hits Two-Year Low: Impact of Russian Oil Sanctions and Strong Dollar

UK Housing Market Sees Robust Growth: February Prices Surge by 3.9% Annually

Adobe Unveils Groundbreaking AI Image Generation Models for Firefly App, Coming to Mobile Soon

Gold Hits Record High Amid Escalating US-China Tariff Dispute

US Stock Futures Dive as IBM Earnings Disappoint and Trade Talks with China Stall

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us